FFCP PHASE1:Hg19::chr1:51434469..51434489,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@CDKN2C |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_CDKN2C_5end |
| Coexpression cluster: | C2591_acute_Hodgkin_Reticulocytes_merkel_Chondrocyte_chronic_NK |
| Association with transcript: | 102bp_to_ENST00000396148, NM_001262_5end |
| EntrezGene: | CDKN2C |
| HGNC: | 1789 |
| UniProt: | P42773Q6ICV4 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@CDKN2C |
|---|
0
10
20
30
40
50
60
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| hematologic cancer | 1.77e-17 | 51 |
| immune system cancer | 1.77e-17 | 51 |
| leukemia | 6.05e-15 | 39 |
| cancer | 2.26e-14 | 235 |
| disease of cellular proliferation | 8.00e-14 | 239 |
| myeloid leukemia | 3.85e-13 | 31 |
| organ system cancer | 3.16e-07 | 137 |
Showing 1 to 7 of 7 entries
